USPTO 2015–2025 USPTO PatentsView US Corporation

Adventus Technologies, Inc.

USPTO PatentsView assignee record - 5 granted patents across 3 technology areas, recorded in grant years 2015–2019. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61B (DIAGNOSIS; SURGERY; Identification).

RSS updates for this company

The verdict

According to USPTO PatentsView, Adventus ranks #44,456 of 49,997 tracked US assignees by granted-patent volume, with 5 patents across 3 technology areas.

#44,456
of 49,997 US assignees by volume
14th percentile
by Innovation Score (24.2/100)
19.8
avg claims per patent
-100%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R44456 · US Corporation #44,456 · 5 grants

GRANTS-MICRO · LOWER-Q · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-USCORP · VEL-DROP · BOOK-FULL

  • GRANTS-MICRO 5 grants
  • LOWER-Q #44,456/49,997
  • PHOTO-FINISH Advantek International
  • CPC-NARROW A61B · 3 areas
  • INNOV-THIN 24.2/100
  • CLAIMS-RICH 19.8 claims/avg
  • TYPE-USCORP US Corporation
  • VEL-DROP -100% vel
  • BOOK-FULL 10/10 fields

Nearest grant-volume peer: Advantek International Corporation (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Adventus’s 24.2 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Innovation-score neighbourhood around Adventus

Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.

score

What this shows Adventus's Innovation Score is 24.2/100 (14th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Source USPTO PatentsView, PlainPatent Innovation Score As of 2015–2025

Does more volume mean deeper claims for Adventus?

Each dot is one of Adventus’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Adventus’s own 19.8 claims/patent is ABOVE the 13.2 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Adventus vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView. 2×2 strategic matrix plotting 9 entities by Granted patents (volume) (X) and Avg claims / patent (Y), with a crosshair dividing the plot into four quadrants. Volume + depthSelective & thoroughVolume over depthLean filer 4.95.05.055.05.05.1 0510152025 Granted patents (volume) Avg claims / patent Advantek International Corporation - 5, 19.4Advantek Internat…Advantek, LLC. - 5, 12.2AdvantekAdvantest America, Inc. - 5, 13.8Advantest AmericaAdvenchen Pharmaceuticals, LLC - 5, 14.2Advenchen Pharmac…Aegion Coating Services, LLC - 5, 15.8Aegion Coating Se…Aegis Industries, Inc. - 5, 3.8Aegis IndustriesAeon Medix Inc. - 5, 13.2Aeon MedixAerWave Medical, Inc. - 5, 10.2Aerwave MedicalAdventus Technologies, Inc. - 5, 19.8Adventus
Adventus vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Adventus's grants concentrate

Adventus Technologies, Inc. is a focused PatentsView assignee: 3 CPC subclasses with 80% of grants classified under A61B (DIAGNOSIS; SURGERY; Identification). Peak complete grant year is 2019 (3 grants) versus a trough of 1 in 2015. By volume, Adventus sits between Advantek International Corporation and AerWave Medical, Inc..

Who files at Adventus's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows Adventus holds 5 patents at rank #44,762, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near Adventus

By rank, the assignees closest to #44,762 in granted patent volume.

Leaders in A61B (Diagnosis)

Other assignees with the most granted patents in Adventus's primary technology class.

Adventus's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

24 14th percentile higher than 14% of 49,997 US assignees

This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

0.511.522.533.5 201520162019 3
USPTO utility patent grants by year · 2015–2019

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table
Adventus Technologies, Inc. patent grants by year, 2015–2025
Year Patents Granted Share of Period
2015 1 20.0%
2016 1 20.0%
2019 3 60.0%

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

What to do with this data

Adventus Technologies, Inc.'s patent record in context - here's where to go next.

  • Adventus Technologies, Inc.'s lead technology class is A61B (DIAGNOSIS; SURGERY; Identification), 80% of its portfolio - see every assignee active in that class. Explore A61B
  • Ranked #44,456 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
  • Compare Adventus Technologies, Inc. against Advantek International Corporation, an assignee filing at a similar volume. Compare portfolios
  • Innovation Score of 24.2/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.